Eli Lilly logo

Eli Lilly

Venture Capital

Lilly is a global health care leader that unites caring with discovery to make life better for people around the world.

Founded 1876 United States Lebanon, United States over-10k employees Biotechnology, Life Sciences

105

Total Investments

90

Portfolio Companies

-

Exits

2

Industries

General Information

Industries Biotechnology, Life Sciences

Company Overview

Founded 1876
Employees over-10k
Location United States Lebanon, United States
Website lilly.com

Investment Criteria

Investment Thesis

•••••• •••••• ••••••

About Eli Lilly

Lilly is a global health care leader that unites caring with discovery to make life better for people around the world. For more than a century, we have stayed true to a core set of values - excellence,integrity, and respect for people - that guide us in all we do: discovering medicines that meet real needs, improving the understanding and management of disease, and giving back to communities through philanthropy and volunteerism. General Information and Guidelines: Eli Lilly and Company strives to create informative and engaging online communities that share information in meaningful ways. We welcome and encourage your participation and engagement in thoughtful and respectful discourse. When you engage with Lilly on LinkedIn (and any other of Lilly's social media channels), you are agreeing to these Community Guidelines in addition to the Terms and Conditions or other legal notices provided by Lilly and those of LinkedIn: you have any questions about a Lilly therapy or medicine, please contact our customer care line at 1-800-LillyRx (1-800-545-5979) between the hours of 9:00am - 5:00pm EST.

Recent Investments (105)

View All
Company Stage Amount Date
Series A •••••• Jul 2026
Post Ipo Equity •••••• Jun 2026
Acquisition •••••• May 2026
Post Ipo Equity •••••• May 2026
Private Equity •••••• Apr 2026
Portfolio company •••• ••••
Series B •••••• Apr 2026
Portfolio company •••• ••••
Acquisition •••••• Apr 2026
Portfolio company •••• ••••
Series B •••••• Mar 2026
Portfolio company •••• ••••
Acquisition •••••• Mar 2026
Portfolio company •••• ••••
Corporate •••••• Feb 2026

See all 105 investments →

Latest News

Alchemab lands £25m from British Business Bank in record life sciences bet

Jul 09, 2026

Alchemab Therapeutics secures €29.3 million as British Business Bank makes its largest life sciences investment yet

Jul 09, 2026

All startup & investor data, one platform.

Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.

Access Millions of Companies and 50K+ Investors

Signal-based outbound intelligence for sales, agencies, and investors.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes